共 10 条
[1]
Lan K.K.G., DeMets D.L., Discrete sequential boundaries for clinical trials, Biometrika, 70, pp. 659-663, (1983)
[2]
Kim K., DeMets D.L., Design and analysis of group sequential tests based on the type I error spending rate function, Biometrika, 74, pp. 149-154, (1987)
[3]
Pocock S.J., Group sequential methods in the design and analysis of clinical trials, Biometrika, 64, pp. 191-199, (1977)
[4]
O'Brien P.C., Fleming T.R., A multiple testing procedure for clinical trials, Biometrics, 35, pp. 549-556, (1979)
[5]
Lan K.K.G., DeMets D.L., Halperin M., More flexible sequential and nonsequential designs in long‐term clinical trials, Communications in Statistics, Theory and Methods, 13, pp. 2339-2353, (1984)
[6]
Lan K.K.G., DeMets D.L., Group sequential procedures: calender versus information time, Statistics in Medicine, 8, pp. 1191-1198, (1989)
[7]
Slud E., Wei L.J., Two‐sample repeated significance tests based on the modified Wilcoxon statistic, Journal of the American Statistical Association, 77, pp. 862-868, (1982)
[8]
Wang S.K., Tsiatis A.A., Approximately optimal one‐parameter boundaries for group sequential trials, Biometrics, 43, pp. 193-199, (1987)
[9]
Pocock S.J., Interim analysis for randomized clinical trials: the group sequential approach, Biometrics, 38, pp. 153-162, (1982)
[10]
Lachin J.M., Foulkes M.A., Evaluation of sample size and power for analysis of survival with allowance for nonuniform patient entry, losses to follow‐up, noncompliance, and stratification, Biometrics, 42, pp. 507-519, (1986)

